Abstract
Living organisms exhibit specific responses when confronted with sudden environmental changes. The ability of cells to acclimatise to a new environment is the basis of adaptive modification. Adaptation involves a number of cellular and biochemical alterations including (i) changes in metabolic homeostasis and (ii) reprogramming of gene expression. Changes in metabolic pathways are generally short-lived and reversible; the consequences of reprogrammed gene expression are long-term and may lead to permanent alteration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124–1136.
Flack J, Kimura Y, Engelman RM, Das DK. Preconditioning the heart by repeated stunning improves myocardial salvage. Circulation 1991; 84: III369–III374.
Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS. Ischaemic preconditioning: present position and future directions. Cardiovasc Res 1998; 37: 21–33.
Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994; 15: 19–25.
Maulik N, Das DK. Hunting for differentially expressed mRNA species in preconditioned myocardium. Ann N Y Acad Sci 1996; 793: 240–258.
Das DK, Moraru II, Maulik N, Engelman RM. Gene expression during myocardial adaptation to ischemia and reperfusion. Ann N Y Acad Sci 1994; 723: 292–307.
Das DK, Engelman RM, Kimura Y. Molecular adaptation of cellular defenses following preconditioning of the heart by repeated ischemia. Cardiovasc Res 1993; 27: 578–584.
Yamashita N, Hoshida S, Nishida M et al. Time course of tolerance to ischemia-reperfusion injury and induction of heat shock protein 72 by heat stress in the rat heart. J. Mol Cell Cardiol 1997; 29: 1815–1821.
Maulik N, Sharma HS, Das DK. Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol 1996; 28: 1261–1270.
Moraru II, Engelman DT, Engelman RM et al. Myocardial ischemia triggers rapid expression of mitochondrial genes. Surg Forum 1994; 45: 315–317.
Sharma HS, Maulik N, Gho BCG, Das DK, Verdouw PD. Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Mol Cell Biochem 1996; 157: 111–116.
Maulik N, Das DK. Molecular cloning, sequencing and expression analysis of a fatty acid transport gene in rat heart induced by ischemic preconditioning and oxidative stress. Mol Cell Biochem 1996; 160/161: 241–247.
Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 1994; 90: 2993–3000.
Baxter GF, Goma FFM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br J Pharmacol 1995; 115: 222–224.
Hunter T, Alexander CB, Cooper JA. Protein tyrosine kinases. Ann Rev Biochem 1995; 54: 897–930.
Sadowski HB, Shuai K, Darnell JE, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993; 261: 1739–1744.
Carpenter CL, Auger KR, Chanudhuri M et al. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem 1993; 268: 9478–9483.
Quilliam LA, Huff SY, Rabun KM et al. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc Natl Acad Sci USA 1994; 91: 8512–8516.
Maulik N, Watanabe M, Zu YL et al. Ischemic precon-ditioning triggers the activation of MAP Kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996; 396: 233–237.
Das DK, Maulik N, Yoshida T, Engelman RM, Zu YL. Preconditioning potentiates molecular signaling for myocardial adaptation to ischemia. Ann N Y Acad Sci 1996; 793: 191–209.
Maulik N, Watanabe M, Tosaki A et al. Tyrosine kinase regulation of phospholipase D-protein C kinase pathway in ischemic preconditioning. J Am Coll Cardiol 1996; 27: 385A (abstract).
Prasad MR, Popescu L, Moraru II, Liu X, Engelman RM, Das DK. Role of phospholipase A2 and phospholipase C in myocardial ischemic reperfusion injury. Am J Physiol 1991; 260: H877–H883.
Cohen MV, Liu Y, Liu GS et al. Phospholipase D plays a major role in ischemic preconditioning in rabbit heart. Circulation 1996; 94: 1713–1718.
Moraru II, Popescu L, Maulik N, Liu X, Das DK. Phospholipase D signaling in ischemic heart. Biochim Biophys Acta 1992; 1139: 148–154.
Trifan OC, Popescu LM, Tosaki A, Cordis G, Das DK. Ischemic preconditioning involves phospho-lipase D. Annals N.Y. Acad Sci 1996; 793: 485–488.
Tosaki A, Maulik N, Cordis GA, Trifan OC, Popescu LM, Das DK. Ischemic preconditioning triggers phospholipase D signaling in the rat heart. Am J Physiol 1997; 273: H1860–H1866.
Billah MM. Phospholipase D and cell signaling. Curr Opin Immunol 1993; 5: 114–123.
Das DK, Engelman RM, Rousou JA, Breyer RH, Otani H, Lemeshow S. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol 1986; 251: H71–H79.
Moraru II, Jones RM, Popescu L, Engelman R, Das DK.Prazosin reduces myocardial ischemia/reperfusion-induced Ca2+ overloading in rat heart by inhibiting phosphoinositide signaling. Biochim Biophys Acta 1995; 1268: 1–8.
Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK. The role of protein kinase C in ischemic/reperfused preconditioning isolated rat hearts. J Cardiovasc Pharmacol 1996; 28: 723–731.
Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Ann Rev Biochem 1993; 62: 453–481.
Meisenhelder J, Suh PG, Rhee SG, Hunter T. Phospholipase C gamma is substrate for the PDGF and EGF receptor protein tyrosine kinases in vivo and in vitro. Cell 1989; 57: 1109–1122.
Ha KS, Exton JH. Differential translocation of protein kinase C isozymes by thrombin and platelet derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J Biol Chem 1993; 268: 10534–10539.
Schmidt M, Huwe SM, Fasselt B et al. Mechanisms of phospholipase D stimulation by m3 muscarinic acetylcholine receptors. Evidence for involvement of tyrosine phosphorylation. Eur J. Biochem 1994; 225: 667–675.
Rivard N, Rydzewska G, Lods JS, Martinex LJ, Morisset J. Pancreas growth, tyrosine kinase, Ptdlns 3-kinase, and PLD involve gigh-affinity CCK-receptor occupation. Am J Physiol 1994; 266: G62–G70.
Bourgoin S, Grinstein S. Peroxides of vanadate induce activation of phospholipase D in HL-60 cells. Role of tyrosine phosphorylation. J Biol Chem 1992; 267: 11908–11916.
Fialkow L, Chan CK, Chan S, Grinstein S, Downey GP. Regulation of tyrosine phosphorylation in neutrophils by the NADPH oxidase. Role of reactive oxygen intermediates. J. Biol Chem 1993; 268: 17131–17137.
Natarajan V, Scribner WM, Taher MM. 4-hydroxynonenal, a metabolite of lipid peroxidation, activates phospholipase D in vascular endothelial cells. Free Rad Biol Med 1993; 15:365–375.
Uings IJ, Thompson NT, Randall RW et al. Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil. Biochem J. 1992; 281: 597–600.
Natarajan V, Vepa S, Verma RS, Scribner WM. Inhibitors of tyrosine kinases and protein tyrosine phosphatases modulate hydrogen peroxide-induced activation of endothelial cell phospholipase D. Am J Physiol (in press)
Prasad MR, Jones RM. Enhanced membrane protein kinase C activity in myocardial ischemia. Basic Res Cardiol 1992; 87: 19–26.
Henrich CJ, Simpson PC. Differential acute and chronic response of protein kinase C in cultured neonatal rat heart myocytes to al-adrenergic and phorbol ester stimulation. J Mol Cell Cardiol 1988; 20: 1081–1085.
Fearon CW, Tashjian AH. Thyrotropin-releasing hormone induces redistribution of protein kinase C in GH4C1 rat pitutary cells. J Biol Chem 1985; 260: 8366–8371.
Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation Am J Physiol 1994; 266: H1145–H1152.
Mitchell MB, Meng X, Brown J, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C activation. Am J. Physiol 1994; 266: H1145–H1152.
Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233: 305–312.
Maulik N, Sharma HS, Das DK. Induction of heme oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol 1996; 28:1261–1270.
Das DK, Engelman RM, Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischemia. Cardiovasc Res 1993; 27: 578–584.
Brand T, Sharma HS, Fleischmann KE et al. Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res 1992; 71: 1351–1360.
Heads RJ, Latchman DS, Yellon DM. Differential stress protein mRNA expression during early ischemic preconditioning in the rabbit heart and its relationship to adenosine receptor function. J. Mol Cell Cardiol 1995; 27: 2133–2148.
Bugge E, Ytrehus K. Ischemic preconditioning is protein kinase C dependent but not through stimulation of a adrenergic or adenosine receptors in the isolated rat heart. Cardiovas Res 1995; 29: 401–406.
Dixon BS, Sharma RV, Dickerson T, Fortune J. Bradykinin and angiotensin II: activation of protein kinase C in arterial muscle. Am J Physiol. 1994; 266: C1406–C1420.
Goto M, Liu Y, Yang XM, Ardeil JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77:611–621
Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995; 27: 883–892.
Yamazaki T, Komuro I, Kudoh S et al. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem 1996; 271: 3221–3228.
Lenormand P, Sardet C, Pages G, L’Allemain G, Brunet A, Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42 MAPK and p44 MAPK) but not of their activator MAP kinase kinase (p45 MAPK) in fibroblasts. J Cell Biol. 1993; 122,1079–1088.
Force T, Bonventrem JV, Heidecker G, Rapp U, Avruch J, Kyriakis LM. Enzymatic characteristics of thew Raf-1 protein kinase. Proc Natl Acad Sci USA, 1994; 91: 1270–1274.
Zu Y-L, Ai Y, Gilchrist A et al. High expression and activation of MAP kinase-activated protein kinase 2 in myocardium. J Mol Cell Cardiol 1997; 29: 2150–2168.
Maulik N, Yoshida T, Zu Y-L, Das DK. Ischemic preconditioning triggers a tyrosine kinase-dependent signal transduction process involving 38P MAP kinases and MAPKAP kinase 2. J Mol Cell Cardiol 1997; 29: A272 (abstract).
Egan SE, Weinberg, RA. The pathway to signal achievement. Nature 1993; 65:781–783.
Davis RJ. MPKs: new JNK expands the group. Trends Biochem Sci 1994; 19: 470-447.
Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davies RJ. MKK3 and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996; 365: 781–783.
Olson MF, Ashworth A, Hall A. An essential role for rho, rac and cdc 42 GTPases in cell cycle progression through GI. Science 1995; 269: 1270–1272.
Doza YN, Cuenda A, Thomas GM, Cohen P, Nebreda AR. Activation of the MAP kinase homologue RK requires the phosphorylation of Thr-180 & Thr-182 and both residues are phosphorylated in chemically stressed KB cells. FEBS Lett. 1995; 364: 223–228.
Raingeaud J, Gupta S, Rogers J, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995; 270: 7420–7426.
Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ. MKK3 & MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996; 16:1247–1255.
Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase 2 and phosphorylation of the small heat shock proteins. Cell 1994; 78: 1027–1037.
Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739–746.
Derijard B, Raingeaud J, Barrett T et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995; 267: 682–685.
Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolality in mammalian cells. Science 1994; 265: 808–811.
Freshney NW, Rawlinson L, Guesdon F et al. Interleukin 1 activates a novel protein kinase cascade that results in the phosphorylation of HSP 27. Cell 1994; 78: 1039–1049.
Ciocca DR, Oesterreich S, Chamness GC, Mc Guire WL, Fuqua SAW. Biological and clinical implications of heat shock protein 27000: a review. J Natl Cancer Inst 1993; 85: 1558–1570.
Stokoe D, Engel K, Campbell DG, Cohen P, Gaeste M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS 1992; 313: 307–313.
Zu YL, Ai Y, Gilchrist A, Labadia ME, Sha’afi RI, Huang CK. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 1996; 87: 5287–5296.
Zu YL, Ai Y, Huang CK. Characterization of an autoinhibitory domain in human mitogen activated protein kinase activated protein kinase 2. J Biol Chem 1995; 270: 202–206.
Maulik N, Wei ZJ, Engelman RM et al. Interleukin-1α preconditioning reduces myocardial ischemic reperfusion injury. Circulation 1993; 88:11387–11394.
Maulik N, Watanabe M, Engelman D et al. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol 1995; 269: C907–C916.
Landry J, Lambert H, Zhou M et al. Human HSP 27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J. Biol Chem 1992; 267: 794–803.
Das DK, Maulik N, Engelman RM, Rousou JA, Deaton D, Flack JE. Signal transduction pathway leading to HSP 27 and HSP 70 gene expression during myocardial adaptation to stress. Ann N Y Acad Sci 1998; in press.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Das, D.K. (1998). Intracellular Signalling Mechanisms in Myocardial Adaptation to Ischaemia. In: Baxter, G.F., Yellon, D.M. (eds) Delayed Preconditioning and Adaptive Cardioprotection. Developments in Cardiovascular Medicine, vol 207. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5312-6_5
Download citation
DOI: https://doi.org/10.1007/978-94-011-5312-6_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6231-2
Online ISBN: 978-94-011-5312-6
eBook Packages: Springer Book Archive